Enanta Pharmaceuticals
Presença
Enanta Pharmaceuticals é uma das ...
Enanta Pharmaceuticals é uma empresa listada sob o símbolo ENTA (US).
Executivos
Veja o organograma con seus 14 executivos principais
Biografias mais buscadas da Enanta Pharmaceuticals
- Jay Luly, President, Chief Executive Officer and Director
- Kristine Peterson, Director
- Terry Vance, Director
Recentes movimentos de executivos em Enanta Pharmaceuticals
- Matthew Kowalsky, ingressou na Companhia como Chief Legal Officer (Notícia publicada em 30 de abril de 2024).
- Nathaniel Gardiner, Senior Vice President and General Counsel, irá se aposentar em 30 de mar. de 2024 (Notícia publicada em 27 de dezembro de 2023).
Criar um alerta
para seguir os movimentos de executivos da Enanta Pharmaceuticals.
Farmacêutica
Enanta Pharmaceuticals possui 1.861 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- MedMen has filed for bankruptcy protection (publicado em 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Enanta Pharmaceuticals
- Enanta Pharmaceuticals to Host Conference Call on August 8 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Third Quarter Ended June 30, 2022 | Enanta Pharmaceuticals, Inc.
- Enanta Pharmaceuticals Announces Positive Data from a Phase 1 Clinical Study of EDP-235, its Oral 3CL Protease Inhibitor Designed for the Treatment of COVID-19 | Enanta Pharmaceuticals, Inc.
- Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer | Enanta Pharmaceuticals, Inc.
- Enanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2022 | Enanta Pharmaceuticals, Inc.
- Enanta Pharmaceuticals to Participate in Two Investor Conferences in June | Enanta Pharmaceuticals, Inc.
- Enanta Pharmaceuticals Reports Topline Data from the RSVP Study of EDP-938 in Otherwise Healthy Adults with Community-Acquired Respiratory Syncytial Virus (RSV) | Enanta Pharmaceuticals, Inc.
- Press Releases | Enanta Pharmaceuticals, Inc.
- Press Releases | Enanta Pharmaceuticals, Inc.
- Press Releases | Enanta Pharmaceuticals, Inc.
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2022 With Webcast and Conference Call Today at 4:30 p.m. ET | Enanta Pharmaceuticals, Inc.
- View more press releases Close
Redes sociais sobre Enanta Pharmaceuticals
- Enanta Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
- Enanta Pharmaceuticals na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Jay Luly 
Ligue para a Enanta Pharmaceuticals em +1 617...
